Home » Topics » Regulatory

Regulatory
RSS

Mexiletine effectively controls spasmodic torticollis in treatment-refractory patients

Jan. 8, 1999

Interneuron receives milestone payment from Lilly under Prozac agreement

Jan. 7, 1999

FDA approves OTC status for Elan's nicotine patch

Jan. 7, 1999

Proleukin receives orphan drug status for two new indications

Jan. 7, 1999

Levofloxacin cleared for new indication by FDA

Jan. 5, 1999

Important end-of-year approval by FDA: Celebrex for arthritis

Jan. 4, 1999

Expanded use of Photofrin approved by FDA

Jan. 4, 1999

Prometrium cleared for U.S. marketing for HRT

Jan. 4, 1999

New indications for Prograf scheduled for FDA advisory committee review

Dec. 30, 1998

Miltefosine evaluated clinically for the oral treatment of visceral leishmaniasis

Dec. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...